
Generics in Indonesia
Description
Generics in Indonesia
Summary
Generics in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Generics in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
- The Indonesian generics market recorded revenues of $4.4 billion in 2023, representing a compound annual growth rate (CAGR) of 8.1% between 2018 and 2023.
- Market consumption volume increased with a CAGR of 1.3% between 2018 and 2023, to reach a total of 75.0% of total pharma volume in 2023.
- The growth in the consumption volume of generics in Indonesia is driven by government initiatives. For instance, the universal healthcare program, Jaminan Kesehatan Nasional (JKN), has significantly increased access to affordable healthcare services. This program, launched in 2014, provides coverage to the entire population, which has led to a growing reliance on cost-effective medications such as generics.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Indonesia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Indonesia
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia generics market with five year forecasts by both value and volume
- What was the size of the Indonesia generics market by value in 2023?
- What will be the size of the Indonesia generics market in 2028?
- What factors are affecting the strength of competition in the Indonesia generics market?
- How has the market performed over the last five years?
- What are the main segments that make up Indonesia's generics market?
Table of Contents
38 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. Has the government recently implemented any initiatives aimed at boosting the market?
- 8 Company Profiles
- 8.1. PT Kalbe Farma Tbk
- 8.2. PT Sanbe Farma
- 8.3. PT Indofarma Tbk
- 8.4. PT Soho Global Health Tbk
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Indonesia generics market value: $ million, 2018-23
- Table 2: Indonesia generics market volume: % of total pharma volume, 2018-23
- Table 3: Indonesia generics market geography segmentation: $ million, 2023
- Table 4: Indonesia generics market value forecast: $ million, 2023-28
- Table 5: Indonesia generics market volume forecast: % of total pharma volume, 2023-28
- Table 6: PT Kalbe Farma Tbk: Key Facts
- Table 7: PT Kalbe Farma Tbk: Annual Financial Ratios
- Table 8: PT Kalbe Farma Tbk: Key Employees
- Table 9: PT Sanbe Farma: Key Facts
- Table 10: PT Sanbe Farma: Key Employees
- Table 11: PT Indofarma Tbk: Key Facts
- Table 12: PT Indofarma Tbk: Annual Financial Ratios
- Table 13: PT Indofarma Tbk: Key Employees
- Table 14: PT Soho Global Health Tbk: Key Facts
- Table 15: PT Soho Global Health Tbk: Annual Financial Ratios
- Table 16: PT Soho Global Health Tbk: Key Employees
- Table 17: Indonesia Size of Population (million), 2019-23
- Table 18: Indonesia Real GDP (Constant 2010 Prices, $ Billion), 2019-23
- Table 19: Indonesia GDP (Current Prices, $ Billion), 2019-23
- Table 20: Indonesia Inflation, 2019-23
- Table 21: Indonesia Consumer Price Index (Absolute), 2019-23
- Table 22: Indonesia Exchange Rate, 2018-23
- List of Figures
- Figure 1: Indonesia generics market value: $ million, 2018-23
- Figure 2: Indonesia generics market volume: % of total pharma volume, 2018-23
- Figure 3: Indonesia generics market geography segmentation: % share, by value, 2023
- Figure 4: Indonesia generics market value forecast: $ million, 2023-28
- Figure 5: Indonesia generics market volume forecast: % of total pharma volume, 2023-28
- Figure 6: Forces driving competition in the generics market in Indonesia, 2023
- Figure 7: Drivers of buyer power in the generics market in Indonesia, 2023
- Figure 8: Drivers of supplier power in the generics market in Indonesia, 2023
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in Indonesia, 2023
- Figure 10: Factors influencing the threat of substitutes in the generics market in Indonesia, 2023
- Figure 11: Drivers of degree of rivalry in the generics market in Indonesia, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.